ArticleBMC gastroenterology2021

Significant response to atezolizumab plus bevacizumab treatment in unresectable hepatocellular carcinoma with major portal vein tumor thrombus: a case report.

Shohei Komatsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.